Clinical reference Biomarker Directory
Back to directory

Anti-gliadin antibody IgG

Established

Anti-gliadin IgG is an outdated celiac marker, superseded by deamidated gliadin peptide (DGP) IgG testing.

Also known as AGA IgG anti-gliadin IgG
In plain language

Like its IgA counterpart, this older gliadin antibody test has been replaced by more accurate tests, especially a newer version (DGP) that works better, particularly for young children or people who don't make normal amounts of IgA antibody.

Biomarker & context

Anti-gliadin IgG antibodies, like their IgA counterpart, target gliadin and were historically used in celiac disease screening, particularly considered in patients with selective IgA deficiency.

What it indicates

As with anti-gliadin IgA, current guidance considers this test outdated for celiac disease diagnosis, having been replaced by deamidated gliadin peptide (DGP) IgG testing, which shows considerably better diagnostic accuracy.

Diagnosis & clinical testing

DGP IgG testing is preferred in patients with IgA deficiency (who cannot mount a reliable tTG-IgA or gliadin-IgA response) or in children under age 2, where classic serology performs less well.

Guiding treatment

A positive result on this older assay alone is insufficient to diagnose celiac disease; clinicians should pursue tTG-IgA (if IgA-sufficient) or DGP-IgG (if IgA-deficient) confirmatory testing.

Clinical significance

Considered low-accuracy by current guidelines; DGP-IgG is the modern equivalent for IgA-deficient patients.

References
  1. myADLM. (2023). Anti-Gliadin Antibody Assay — Optimal Testing Guide to Lab Test Utilization.